Kalvin editorial desk · 2026
A clear boundary between editorial information and advertising.
1. Purpose
This policy explains how Kalvin approaches advertising while maintaining an editorial wellness publication. It applies to display placements, partnerships, and sponsored messages appearing in 2026.
2. Separation
Advertising is visually and verbally separated from independent articles. A paid placement does not receive editorial endorsement and does not alter our topic selection.
3. Prohibited claims
We do not accept claims that promise guaranteed health outcomes, cure disease, exploit fear, or discourage professional care. Copy must be responsible, supportable, and appropriate for adults.
4. Health products
Products related to supplements, devices, or services may require additional review. Kalvin may decline a placement where evidence, labelling, audience fit, or safety communication is inadequate.
5. Targeting
We do not sell contact-form information or target advertisements using sensitive health inferences. Optional analytics and cookie choices are explained in the cookie policy.
6. Labelling
Sponsored or paid content is labelled in plain language. A reader should be able to distinguish an advertisement from a Kalvin article without technical knowledge.
7. Links
Advertiser links may lead to external policies, checkout systems, or services. Those destinations are responsible for their own content, security, and privacy handling.
8. Reader feedback
Readers may report a misleading or inappropriate placement through contact.php. We review concerns and may pause a placement while information is assessed.
9. Editorial independence
Our writers and editors retain the ability to disagree with commercial language and to publish relevant context. Payment cannot buy a favourable review or a medical conclusion.
10. Contact
Advertising enquiries may be sent to Jalan Melati 15, Menteng, Central Jakarta, Jakarta 10310, Indonesia, or +62 21 7890 1234.
11. Review date
This policy was reviewed on 12 October 2026 and may be updated when platform rules or applicable requirements change.
Before accepting a placement, Kalvin considers the identity of the advertiser, the destination page, the audience, the wording, and the context in which the message will appear. A placement can be declined when the business model or landing page is unclear, when required information is difficult to find, or when the presentation could confuse an advertisement with independent reporting.
Claims should be specific enough to evaluate and should not rely on fear, personal shame, unsupported comparisons, or pressure. Advertisers remain responsible for substantiation, legal disclosures, pricing, terms, and customer support on their own pages. Kalvin’s review of an advertisement is a publication decision, not a certification of the advertiser or its product.
Particular care is applied to health-related services, products, devices, and wellness programmes. We may request evidence, instructions, safety information, audience limitations, and clear contact details before considering a placement. We do not accept copy that discourages qualified care, presents a personal outcome as typical without support, or uses a sensitive condition to target a reader.
Advertising partners do not receive contact-form messages, private correspondence, or a list of readers. Optional measurement is handled according to the cookie policy and reader choice, and reports are intended to describe broad performance rather than identify people. Where a third party processes technical information, the relevant provider’s privacy notice and international processing terms may also apply.
A reader may report a placement through contact.php, by phone at +62 21 7890 1234, or by writing to Jalan Melati 15, Menteng, Central Jakarta, Jakarta 10310, Indonesia. Kalvin aims to acknowledge reports within 10 business days and may request the page address, screenshot, date, and reason for concern. The policy was reviewed on 12 October 2026 and material changes will be dated.
The policy covers display placements, sponsored articles, partnerships, event references, affiliate-style links if used, and messages presented beside editorial material in 2026. It does not make an advertiser a Kalvin contributor or turn a paid message into independent reporting. A placement may be declined when the advertiser, destination, pricing, terms, or customer-support route cannot be understood from the available information.
Claims should be specific, supportable, and proportionate to the evidence. Copy should not use fear, shame, unsupported comparison, personal targeting, or pressure to make a decision. The advertiser remains responsible for its landing page, disclosures, permissions, customer service, and compliance with applicable Indonesian requirements. Kalvin’s review is a publication decision, not an approval of every claim.
Health-related advertising receives additional scrutiny because readers may interpret general language as personal guidance. We may request substantiation, clear audience limits, safety information, instructions, and relevant labelling before considering a placement. We do not accept wording that discourages qualified care, presents an individual outcome as typical without support, or uses a sensitive condition to target a reader. Where the information cannot be assessed responsibly, the placement is not used.
Advertising partners do not receive contact-form messages, private correspondence, or a list of readers. Optional measurement is described in the cookie policy and depends on reader choice. A technical provider may process limited request data for hosting, security, delivery, or aggregate reporting, potentially outside Indonesia, under its own contractual safeguards. Reports are designed to describe broad performance and are not intended to infer a person’s health condition.
Readers may report a misleading or inappropriate placement through contact.php, at Jalan Melati 15, Menteng, Central Jakarta, Jakarta 10310, Indonesia, or by phone at +62 21 7890 1234. Kalvin aims to acknowledge a report within 10 business days and may request the page address, date, screenshot, and reason for concern. A placement may be paused while the information is assessed. This policy was reviewed on 12 October 2026 and material changes will carry a new review date.